PD Dr. Benjamin Frey

Medizinische Fakultät Department of Radiation Oncology

The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy (2021) Filimonova I, Schmidt D, Mansoorian S, Weissmann T, Siavooshhaghighi H, Kuwert T, Bert C, et al. Journal article Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages (2021) Wedekind H, Walz K, Buchbender M, Rieckmann T, Strasser E, Grottker F, Fietkau R, et al. Journal article Low- vs. high-dose radiotherapy in Graves’ ophthalmopathy: a retrospective comparison of long-term results (2021) Weissmann T, Lettmaier S, Donaubauer AJ, Bert C, Schmidt M, Kruse F, Ott O, et al. Journal article The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts (2021) Friščić J, Böttcher M, Reinwald C, Bruns H, Wirth B, Popp S, Walker KI, et al. Journal article, Original article Radon exposure—therapeutic effect and cancer risk (2021) Maier A, Wiedemann J, Rapp F, Papenfuß F, Rödel F, Hehlgans S, Gaipl U, et al. Journal article, Review article Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis (2020) Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, Dürholz K, et al. Journal article Radiomics for selection of patients treated with immuno-radiotherapy: pooled analysis from 6 studies (2020) Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Milic M, Carre A, et al. Conference contribution Reactivation of HCMV during RT of the brain results in critical illness and early mortality (2020) Frey B, Goerig N, Becker I, Donaubauer AJ, Korn K, Überla K, Schmidt M, et al. Conference contribution Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Conference contribution Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells (2020) Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Rouyar A, Milic M, et al. Journal article